RE: Term sheet finalised8 Sep 2021 11:19
Just some basis calculations to contrast the difference the dilution will have at differing share prices...........
Assuming current sp of 17.50p, the $12.5m (£8.9m) equity raise with 10% discount (15.75p) would see approx 56,500,00 shares issued.
Again, assuming current sp of 17.50p, the $12.5m (£8.9m) CLN with 30% premium (20.47p) to equity raise would see approx 43,478,000 shares issued.
So existing 246m shares add 56.50m add 43.48m shares would see a total 345.98m shares in issue an increase of 99.98m figure to raise the $25m combined equity component.
.............
Assuming current sp of 12.50p,(yes hopefully unlikely but could happen if we have a market sell off at the "wrong time") the $12.5m (£8.9m) equity raise with 10% discount (11.25) would see approx 79,000,000 shares issued.
Again, assuming current sp of 12.50p, the $12.5m (£8.9m) CLN with 30% premium (14.62p) to equity raise would see approx 60,875,000 shares issued.
So existing 246m shares add 79.00m add 60.87m shares would see a total 385.87m shares in issue an increase of 139.87m figure to raise the $25m combined equity component.
...........
Assuming current sp of 22.50p, the $12.5m (£8.9m) equity raise with 10% discount (20.25p) would see approx 43,950,000 shares issued.
Again, assuming current sp of 17.50p, the $12.5m (£8.9m) CLN with 30% premium (23.69p) to equity raise would see approx 37,568,000 shares issued.
So existing 246m shares add 43.95m add 37.57m shares would see a total 327.52m shares in issue an increase of 81.52m figure to raise the $25m combined equity component.
............
Assuming current sp of 27.5p, the $12.5m (£8.9m) equity raise with 10% discount (24.75p) would see approx 35,959,000 shares issued.
Again, assuming current sp of 27.5p, the $12.5m (£8.9m) CLN with 30% premium (32.17p) to equity raise would see approx 27,665,000 shares issued.
So existing 246m shares add 35.96m add 27.66m shares would see a total 309.62m shares in issue an increase of 63.62m figure to raise the $25m combined equity component.
BB2